
Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors
LoRusso, Patricia M., Gounder, Mrinal, Jalal, Shadia I., André, Valérie, Kambhampati, Siva Rama Prasad, Loizos, Nick, Hall, Jennifer, Holzer, Timothy R., Nasir, Aejaz, Cosaert, Jan, Kauh, John, ChioreLangue:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-016-0413-0
Date:
February, 2017
Fichier:
PDF, 560 KB
english, 2017